The U.S. Food and Drug Administration today published a new regulation defining the term “gluten-free” for voluntary food labeling. This will provide a uniform standard definition to help the up to 3 million Americans who have celiac disease, an autoimmune digestive condition that can be effectively managed only by eating a gluten free diet.
Category Archives: Food Safety News
FDA announces a voluntary recall of Nova Max Blood Glucose Test Strips
The U.S. Food and Drug Administration is working with Nova Diabetes Care to recall 21 lots of glucose test strips marketed under the brand names Nova Max Blood Glucose Test Strips and Nova Max Plus Glucose Meter Kits. Nova Diabetes Care announced a recall on July 26, 2013.
FDA takes step to help ensure the safety of imported food
In order to implement the bipartisan Food Safety Modernization Act (FSMA) signed by President Obama, the U.S. Food and Drug Administration today issued two proposed rules aimed at helping to ensure that imported food meets the same safety standards as food produced in the United States.
FDA warns consumers about health risks with Healthy Life Chemistry dietary supplement
Today, the U.S. Food and Drug Administration is warning consumers that they should not use or purchase Healthy Life Chemistry By Purity First B-50, marketed as a vitamin B dietary supplement. A preliminary FDA laboratory analysis indicated that the product contains two potentially harmful anabolic steroids, methasterone, a controlled substance and dimethazine. These ingredients are not listed in the label and should not be in a dietary supplement.
Gold Star Smoked Fish Corp. Issues an Alert on Listeria in Rybacka Wies Brand Herring Fillets in Oil "Matjes Sledz w oleju"
Gold Star Smoked Fish Corp., located at 570 Smith Street, Brooklyn, NY 11231, is recalling Rybacka Wies Brand Herring Fillets In Oiii”Matjes Sledz w oleju” due to contamination with Listeria monocytogenes. Listeria monocytogenes can cause serious and sometimes fatal infections in young children, frail or elderly people and others with weakened immune systems.
Read The Complete Story!
FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin
The U.S. Food and Drug Administration today allowed marketing of the Xpert MTB/RIF Assay, the first FDA-reviewed test that can simultaneously detect bacteria that cause tuberculosis (TB) and determine if the bacteria contain genetic markers that makes them resistant to rifampin, an important antibiotic for the treatment of TB.
FDA alerts companies to stop illegal sale of treatments for diabetes
The U.S. Food and Drug Administration is taking action to remove from the market illegal products, including some labeled as dietary supplements, that claim to mitigate, treat, cure or prevent diabetes and related complications. The agency recently issued letters warning 15 companies that the sale of their illegally marketed diabetes products violates federal law. The letters were sent to foreign and domestic companies whose products were sold online and in retail stores.
FDA invites public input on menthol in cigarettes
Today, the U.S. Food and Drug Administration issued an Advance Notice of Proposed Rulemaking (ANPRM) seeking additional information to help the agency make informed decisions about menthol in cigarettes.
Square Mile Cider Company Announces Voluntary Recall of 2,500 Cases of Hard Cider Products
Square Mile Cider Company (SMCC) today announced the voluntary recall of 2,500 cases “Square Mile Original Hard Apple Cider” and “Square Mile Spur & Vine Hopped Apple Cider.”
Read The Complete Story!
FDA permits marketing of first brain wave test to help assess children and teens for ADHD
The U.S. Food and Drug Administration today allowed marketing of the first medical device based on brain function to help assess attention-deficit/hyperactivity disorder (ADHD) in children and adolescents 6 to 17 years old. When used as part of a complete medical and psychological examination, the device can help confirm an ADHD diagnosis or a clinician’s decision that further diagnostic testing should focus on ADHD or other medical or behavioral conditions that produce symptoms similar to ADHD.